Radionetics Oncology · 2 days ago
VP or SVP of Clinical Development
Radionetics Oncology, Inc. is a clinical stage company focused on the discovery and development of novel radiopharmaceuticals for oncology treatments. They are seeking a VP/SVP of Clinical Development to lead clinical trials, provide strategic direction, and collaborate with cross-functional teams to advance their innovative therapies.
Health CareMedicalOncologyPharmaceuticalTherapeutics
Responsibilities
Serve as a medical lead for one or more radioligand therapy programs
Develop and drive the clinical development plan, ensuring alignment with regulatory requirements and the company’s strategic goals
Work closely with the CMO on the design and preparation of clinical trial protocols (first-in-human), statistical analysis plans, and clinical study reports
Provide ongoing medical monitoring and real-time support for clinical trials, including reviewing and interpreting clinical data, assessing safety signals, and determining the medical eligibility of subjects
Perform clinical data review and interpretation, including the preparation of top-line results, integrated summaries of safety and efficacy, and final reports
Serve as a medical expert in interactions with regulatory authorities globally
Prepare and present clinical data during meetings to support regulatory filings and development
Work closely with cross-functional teams, including Research & Discovery, Translational Medicine, Biostatistics, Clinical Operations, Regulatory Affairs, and CMC to ensure seamless program execution, recognizing the unique supply chain and manufacturing needs of RLTs
Establish and maintain relationships with key opinion leaders (KOLs), investigators and clinical site staff to garner clinical insights
Travel to sites to enhance engagement and drive clinical trial enrollment
Lead the preparation of clinical trial results for publication in peer-reviewed journals and presentation at major scientific congresses (e.g., ASCO, ESMO, SNMMI)
Provide internal medical and scientific training to internal teams (e.g., business development, commercial, medical affairs) as needed
Qualification
Required
M.D. required
Board Certification/Eligibility in Oncology, Hematology/Oncology, or Nuclear Medicine is highly preferred
Minimum 6-12+ years of industry clinical development experience, with a focus on oncology
Progressive leadership experience in clinical development, with demonstrated ability to define and execute global clinical strategies for complex therapeutics
Deep knowledge of the oncology landscape, including standard of care, translational research, and emerging therapeutic modalities
Proven experience designing, implementing, and medically overseeing first-in-human/ Phase 1 clinical trials
Preferred
Direct experience with the development, clinical application, or regulatory aspects of radiopharmaceuticals, targeted radionuclide therapy, or nuclear medicine
Understanding of the unique safety, handling, and logistics challenges associated with radioligand therapies
Benefits
Bonus opportunity
Equity
Medical, dental, vision, life, short-term, and long-term disability insurance
401(k) retirement plan with employer match
4 weeks of paid time off (PTO) annually
Generous paid holidays
Company
Radionetics Oncology
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
Funding
Current Stage
Early StageTotal Funding
$82.5M2023-08-14Series A· $52.5M
2021-10-18Seed· $30M
Leadership Team
Recent News
AstuteAnalytica India Pvt. Ltd.
2025-10-23
2025-02-09
Company data provided by crunchbase